Dr. Ankur Nandan Varshney
Consultant
Medical Oncology
13+ years of experience
Fortis Memorial Research Institute (FMRI), Gurgaon Delhi-NCR
Opening Hours
Monday – Friday 8.00 – 7:00 pm
Saturday 9.00 – 8.00 pm
Sunday 10.00 – 9.00 pm
About Doctor
- Dr. Ankur Nandan Varshney is a consultant in the Department of Medical Oncology and Stem Cell Transplant at Fortis Memorial Research Institute.
- He had a rich experience of more than 13 years in the field of Medical Oncology.
- His areas of expertise are in treating solid organ cancers, haematological malignancies and stem cell transplants.
- He is also well-versed in the administration of chemotherapy, immunotherapy, targeted therapy and palliative care.
- He had published more than 30 papers in various international and national journals and had presented much of his research at various international and national conferences.
Qualification & Training
- MBBS – Banaras Hindu University
- MD (General Medicine) – Banaras Hindu University
- DNB (Medical Oncology)- VMMC and Safdarjung Hospital, New Delhi
- Fellowship in Medical Oncology- National Cancer Institute, AIIMS, Jhajjar
Areas of Clinical interests
- Cancer immunotherapy
- GI malignancies
- Urogenital & Gyn ecological cancers
- Multiple myeloma, Lymphoma, Leukaemia
- Paediatric solid tumour
- Stem cell transplant
- Pain and palliative care
Awards:
- Deeptanshu Vedanta Gupta Gold Medal
- ESMO Lung Preceptorship- 2020
- ESH scholarship award- 22nd John Goldman Conference 2020
- Young Investigator Award- SOHO conference, 2022
Memberships:
- European Society of Medical Oncology
- American Society of Clinical Oncology
- International Society of Pediatric Oncology
- Society of Hemato-Oncology
- American Cancer Society
- Indian Society of Medical and Paediatric Oncology
List of Treatments
- Chemotherapy
- Adrenal Cancer Treatment
- Anal Cancer Treatment
- Aplastic Anaemia
- Bladder Cancer Treatment
- Bone Cancer Treatment
- Brain CNS Tumour Treatment – Adults
- Brain CNS Tumours Treatment – Children
- Breast Cancer-Surgical
- Carcinoma of Unknown Primary (CUP) Treatment
- Castleman Disease Treatment
- Cervical Cancer Treatment
- Endometrial Cancer Treatment
- Oesophagus Cancer Treatment
- Ewing Family of Tumours Treatment
- Eye Cancer Treatment
- Gallbladder Cancer Treatment
- Carcinoid Tumours Treatment
- Gastrointestinal Stromal Tumour GIST Treatment
- Gestational Trophoblastic Disease (GTD) Treatment
- Hodgkin Disease Treatment
- Kaposi Sarcoma Treatment
- Kidney Cancer Treatment
- Laryngeal and Hypopharyngeal Cancer Treatment
- Acute Lymphocytic Leukaemia – ALL in Adults
- Leukaemia – Acute Myeloid AML
- Chronic Lymphocytic Leukaemia – CLL
- Chronic Myeloid Leukaemia- CML
- Skin Lymphoma Treatment
- Malignant Mesothelioma Treatment
- Multiple Myeloma Treatment
- Myelodysplastic Syndrome (MDS) Treatment – Preleukemia
- Non-Hodgkin Lymphoma (NHL) Treatment
- Non-Hodgkin Lymphoma In Children
- Osteosarcoma (OS) Treatment
- Ovarian Cancer Surgery
- Pancreatic Cancer
- Penile Cancer Treatment
- Prostate Cancer-Surgical
- Retinoblastoma (RB) Treatment
- Rhabdomyosarcoma (RMS) Treatment
- Soft Tissue Sarcoma Treatment
- Skin Cancer
- Testicular Cancer Treatment
- Thymoma and Thymic Carcinoma Treatment
- Thyroid Cancer Treatment
- Uterine Sarcoma
- Vaginal Cancer Treatment
- Autologous Stem Cell Transplant for Lymphoma
- Allogeneic Bone Marrow Transplant
- Pediatric Bone Marrow Transplant
- Thalassemia Treatment
- Ovarian Germ Cell Tumour
- Invasive Lobular Carcinoma
- Chronic Myelomonocytic Leukaemia – CMML
- Leukaemia in Children
- Liver Cancer
- Lung Cancer Treatment